Horm Metab Res 2019; 51(06): 362-366
DOI: 10.1055/a-0902-8476
Endocrine Care
© Georg Thieme Verlag KG Stuttgart · New York

Long-Term Treatment with Calcitriol in Postsurgical Hypoparathyroidism Leads to Renal Function Decline

Elien Coudenys
1   Department of Endocrinology, UZ Brussel, Vrije Universiteit Brussel (VUB), Jette, Belgium
,
Tess Van Meerhaeghe
2   Department of Nephrology, Erasmus Ziekenhuis, Université Libre de Bruxelles (ULB), Bruxelles, Belgium
,
David Unuane
1   Department of Endocrinology, UZ Brussel, Vrije Universiteit Brussel (VUB), Jette, Belgium
,
Ronald Buyl
3   Department of Statistics, Vrije Universiteit Brussel (VUB), Jette, Belgium
,
Bert Bravenboer
1   Department of Endocrinology, UZ Brussel, Vrije Universiteit Brussel (VUB), Jette, Belgium
› Author Affiliations
Further Information

Publication History

received 14 January 2019

accepted 30 April 2019

Publication Date:
17 June 2019 (online)

Abstract

Hypoparathyroidism is a rare endocrine disease with insufficient parathyroid hormone levels. Replacing the missing hormone is not yet a standard therapy. The objective of this retrospective cohort study was to evaluate if the usual therapy regimens of postsurgical hypoparathyroidism with calcitriol have a negative effect on renal function. We performed a chart analysis of patients who were seen in a tertiary care hospital in Brussels, Belgium. A total of 101 subjects were identified as patients with permanent post-surgical hypoparathyroidism, based on the hospital records of patients who underwent a total thyroidectomy between 1996 and 2016, while still being treated with calcitriol. Patients with pre-existing renal insufficiency and/or active malignancy were excluded. The cohort was predominantly female of Caucasian origin. Renal function was evaluated before and after surgery (with a maximum follow-up of 12 years), using the CKD-EPI equation. A multivariate linear regression model was used to correlate renal function decline with the duration of calcitriol therapy, while correcting for the mean calcium phosphate product and age. We found a statistically significant (p=0.027) relationship between the duration of calcitriol treatment and renal function decline at a rate of 1.06 ml/min/1.73 m2 per year of calcitriol therapy. Our study, although being retrospective, is the first one to demonstrate a relationship between the cumulative use of calcitriol therapy and renal function decline.

 
  • References

  • 1 Arlt W, Fremerey C, Callies F. et al. Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D. Eur J Endocrinol 2002; 146: 215-222
  • 2 Sikjaer T, Rejnmark L, Rolighed L. et al. The effect of adding PTH(1-84) to conventional treatment of hypoparathyroidism: A randomized, placebo-controlled study. J Bone Miner Res 2011; 26: 2358-2370
  • 3 Puzziello A, Rosato L, Innaro N. et al. Hypocalcemia following thyroid surgery: Incidence and risk factors. A longitudinal multicenter study comprising 2 631 patients. Endocrine 2014; 47: 537-542
  • 4 Underbjerg L, Sikjaer T, Mosekilde L. et al. Cardiovascular and renal complications to postsurgical hypoparathyroidism: A Danish nationwide controlled historic follow-up study. J Bone Miner Res 2013; 28: 2277-2285
  • 5 Bilezikian JP, Khan A, Potts JT. et al. Hypoparathyroidism in the adult: Epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. J Bone Miner Res 2011; 26: 2317-2337
  • 6 Bollerslev J, Rejnmark L, Marcocci C. et al. European Society of Endocrinology clinical guideline: Treatment of chronic hypoparathyroidism in adults. Eur J Endocrinol 2015; 173: G1-G20
  • 7 Cozzolino M, Dusso A, Slatopolsky E. Role of calcium-phosphate product and bone-associated proteins on vascular calcification in renal failure. J Am Soc Nephrol 2001; 12: 2511-2516
  • 8 Mitchell DM, Regan S, Cooley MR. et al. Long-Term follow-up of patients with hypoparathyroidism. J Clin Endocrinol Metab 2012; 97: 4507-4514
  • 9 Bolland MJ, Grey A, Avenell A. et al. Calcium supplements with or without vitamin D and risk of cardiovascular events: Reanalysis of the Women’s Health Initiative limited access dataset and meta-analysis. BMJ 2011; 342: d2040
  • 10 Jackson RD, LaCroix AZ, Gass M. et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 2006; 354: 669-683
  • 11 Michels WM, Grootendorst DC, Verduijn M. et al. Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size. Clin J Am Soc Nephrol 2010; 5: 1003-1009
  • 12 Levey AS, Stevens LA, Schmid CH. et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612
  • 13 López-Suárez A, Beltrán-Robles M, Elvira-González J. et al. Comparison of the MDRD and the CKD-EPI equations to estimate the glomerular filtration rate in the general population. Med Clin (Barc). 2010. 134 617-623
  • 14 Florkowski CM, Chew-Harris JSC. Methods of estimating GFR - Different equations including CKD-EPI. Clin Biochem Rev 2011; 32: 75-79
  • 15 Winer KK, Ko CW, Reynolds JC. et al. Long-term treatment of hypoparathyroidism: A randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium. J Clin Endocrinol Metab 2003; 88: 4214-4220
  • 16 Curhan GC, Willett WC, Speizer FE. et al. Twenty-four-hour urine chemistries and the risk of kidney stones among women and men. Kidney Int 2001; 59: 2290-2298